Rxivist logo

Medial temporal atrophy in preclinical dementia: visual and automated assessment during six year follow-up

By Gustav MÃ¥rtensson, Claes HÃ¥kansson, Joana B Pereira, Sebastian Palmqvist, Oskar Hansson, Danielle van Westen, Eric Westman

Posted 06 Mar 2020
bioRxiv DOI: 10.1101/2020.03.05.979229 (published DOI: 10.1016/j.nicl.2020.102310)

Medial temporal lobe (MTL) atrophy is an important morphological marker of many dementias and is closely related to cognitive decline. In this study we aimed to characterize longitudinal progression of MTL atrophy in 93 individuals with subjective cognitive decline and mild cognitive impairment followed up over six years, and to assess if clinical rating scales are able to detect these changes. All MRI images were visually rated according to Scheltens' scale of medial temporal atrophy (MTA) by two neuroradiologists and AVRA, a software for automated MTA ratings. The images were also segmented using FreeSurfer's longitudinal pipeline in order to compare the MTA ratings to volumes of the hippocampi and inferior lateral ventricles. We found that MTL atrophy rates increased with CSF biomarker abnormality, used to define preclinical stages of Alzheimer's Disease. Both AVRA's and the radiologists' MTA ratings showed a similar longitudinal trajectory as the subcortical volumes, suggesting that visual rating scales provide a valid alternative to automatic segmentations. While the MTA scores from each radiologist showed strong correlations to subcortical volumes, the inter-rater agreement was low. We conclude that the main limitation of quantifying MTL atrophy with visual ratings in clinics is the subjectiveness of the assessment.

Download data

  • Downloaded 132 times
  • Download rankings, all-time:
    • Site-wide: 121,470
    • In neuroscience: 18,673
  • Year to date:
    • Site-wide: 106,076
  • Since beginning of last month:
    • Site-wide: 114,976

Altmetric data


Downloads over time

Distribution of downloads per paper, site-wide


PanLingua

Sign up for the Rxivist weekly newsletter! (Click here for more details.)


News